Alnylam Pharmaceuticals Inc (ALNY)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ALNY? Forum Prognose

Finanzdaten der Alnylam Pharmaceuticals Inc-Aktie (ALNY)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	12.42% 494.33	439.72	750.53	318.75	319.29
Cost Of Revenue	24.12% 54.61	71.97	79.47	75.34	41.43
Gross Profit	19.57% 439.72	367.74	671.06	243.42	277.86
Operating Expenses	0.20% 483.15	484.15	457.19	473.25	427.67
Interest Income/Expense	12.49% 35.25	31.34	30.89	30.04	28.95
Benefits Costs and Expenses	3.37% 557.92	577.40	599.79	592.96	491.65
Costs And Expenses	3.30% 537.77	556.12	536.66	548.59	469.10
Operating Income/Loss	62.69% -43.44	-116.40	213.87	-229.83	-149.81
Nonoperating Income/Loss	5.31% -20.15	-21.28	-63.13	-44.38	-22.55
Income/Loss From Continuing Operations Before Tax	53.82% -63.59	-137.69	150.74	-274.21	-172.36
Income Tax Expense/Benefit	1,183% 2.348	0.183	2.988	1.815	1.739
Income/Loss From Continuing Operations After Tax	52.18% -65.94	-137.87	147.75	-276.02	-174.10
Net Income/Loss	52.18% -65.94	-137.87	147.75	-276.02	-174.10
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	52,677% 126.14	0.239	125.22	124.66	124.11
Diluted Average Shares	52,677% 126.14	0.239	131.34	124.66	124.11
Basic Earnings Per Share	52.29% -0.52	-1.09	1.18	-2.21	-1.40
Diluted Earnings Per Share	52.29% -0.52	-1.09	1.15	-2.21	-1.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

BNTX

$113.08

1.56%

ARGX

$623.82

0.35%

BGNE

$176.50

1.02%

UTHR

$359.58

0.16%

MRNA

$39.39

0.43%